Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...

Precision for Medicine, explains why radiopharmaceuticals are unique for patients with cancer and what makes them challenging ...

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Annex 1 reframes sterility assurance from prescriptive checklists to a performance-based, prevention-first contamination control strategy spanning the full product life cycle. Sponsor gaps—limited ...

Procurement frameworks now incorporate resilience criteria, enabling tender preference for diversified, Europe-based manufacturing and contingency capacity over lowest price, reshaping economics for ...

Tracy Beth Høeg said she was fired; Katherine Szarama departs as acting CBER director but remains at FDA, signaling rapid ...

Collectively, the deals reposition vaccines as long-horizon disease-modifying infrastructure, leveraging epidemiologic and mechanistic links between infections (eg, VZV, EBV) and neurodegeneration, ...

Bristol Myers Squibb collaborates with Anthropic to accelerate drug development, manufacturing quality systems, and regulatory documentation via AI integration. Bristol Myers Squibb (BMS) has ...

Building resilient, adaptable operations capable of evolving alongside the rapid transformation of the biologics industry is key for downstream processing.

Legacy packaging paradigms impede sustainability gains; early lifecycle management decisions, even for secondary components like syringe cartons, can reduce long-term material use, emissions, and ...

Benralizumab gained approval for adult and pediatric hypereosinophilic syndrome with a 65% flare-risk reduction, underscoring lifecycle strategies that impose distinct dosing, formulation, and ...